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Bone Marrow Precursors of Nonobese Diabetic Mice Develop
into Defective Macrophage-Like Dendritic Cells In Vitro1
Tatjana Nikolic,2 Marjolijn Bunk, Hemmo A. Drexhage, and Pieter J. M. Leenen
The NOD mouse spontaneously develops autoimmune diabetes. Dendritic cells (DC) play a crucial role in the autoimmune
response. Previous studies have reported a defective DC generation in vitro from the NOD mouse bone marrow (BM), but a
deviated development of myeloid precursors into non-DC in response to GM-CSF was not considered. In this study, we demon-
strate several abnormalities during myeloid differentiation of NOD BM precursors using GM-CSF in vitro. 1) We found reduced
proliferation and increased cell death in NOD cultures, which explain the previously reported low yield of DC progeny in NOD.
Cell yield in NOR cultures was normal. 2) In a detailed analysis GM-CSF-stimulated cultures, we observed in both NOD and NOR
mice an increased frequency of macrophages, identified as CD11c/MHCII cells with typical macrophage morphology, pheno-
type, and acid phosphatase activity. This points to a preferential maturation of BM precursors into macrophages in mice with the
NOD background. 3) The few CD11c/MHCIIhigh cells that we obtained from NOD and NOR cultures, which resembled proto-
typic mature DC, appeared to be defective in stimulating allogeneic T cells. These DC had also strong acid phosphatase activity
and elevated expression of monocyte/macrophage markers. In conclusion, in this study we describe a deviated development of
myeloid BM precursors of NOD and NOR mice into macrophages and macrophage-like DC in vitro. Potentially, these anomalies
contribute to the dysfunctional regulation of tolerance in NOD mice yet are insufficient to induce autoimmune diabetes because
they occurred partly in NOR mice. The Journal of Immunology, 2004, 173: 4342–4351.
I nsulin-dependent diabetes mellitus (IDDM)3 or type I diabe-tes develops as a result of an autoimmune destruction of the cells in the islets of Langerhans (1). To investigate the
pathogenesis of IDDM, animal models such as the nonobese dia-
betic (NOD) mouse and the biobreeding rat have proved to be
valuable tools. These animals develop IDDM spontaneously. In
NOD mice, the sequence of events that occurs during this process
closely resembles the disease development in humans (2).
Dendritic cells (DC) and macrophages play a pivotal role in the
initiation and progression of the autoimmune response and the fi-
nal destruction of the  cells. In the pancreas of neonatal NOD
mice, elevated numbers of DC and macrophages are present (3).
Furthermore, an accumulation of DC and macrophages at around
4 wk of age marks the initiation of the autoimmune insulitis before
the infiltration of lymphocytes (4, 5). The final  cell destruction
is thought to occur by the activity of both lymphocytes and mac-
rophages (4, 6). Together, these findings underline the important
roles of DC and macrophages in the different stages of the inflam-
matory process in the pancreas.
As APC, DC play a prominent role in both central and periph-
eral tolerance. Therefore, deficient induction and maintenance of
tolerance by aberrant DC would be key to the initiation of auto-
immunity (7). According to such a view, a hampered negative
selection by aberrant thymus DC leads to the incomplete deletion
of autoreactive T cells. In addition, abnormal DC in the periphery
might not stimulate regulatory T cells sufficiently, thus contribut-
ing to a failing control of the autodestructive process in the target
organ. These notions have led to an extensive investigation of a
putative deficient function of DC in type I diabetes. In both hu-
mans and biobreeding BB-DP rats, a functional deficiency of DC
has been observed. Fewer DC, an immature phenotype, and im-
paired stimulatory capacity have been found in both human and rat
DC (8–10). In contrast to these studies, ex vivo isolated NOD
mouse DC from spleen and lymph nodes demonstrated only minor
phenotypic and functional aberrations (11, 12).
In marked contrast to the reports on ex vivo DC isolated from
prediabetic NOD mice, in vitro studies show significant abnormal-
ities in DC yield and development when NOD DC are generated
from bone marrow (BM) precursors (12–16). Studies where NOD
BM precursors are stimulated with GM-CSF alone show genera-
tion of low numbers of DC that display an immature phenotype
and a poor T cell-stimulatory capacity (13, 14, 17). However, in
the latter reports, the authors describe the phenotypic and func-
tional anomalies of the in vitro generated NOD myeloid DC, with-
out assessing a possibly deviated development of NOD myeloid
precursors into non-DC. Because GM-CSF is an important inflam-
matory cytokine that influences the function and development of
DC but also of other myeloid cell types (18), we decided to in-
vestigate the in vitro effects of GM-CSF on the generation of NOD
BM cells in detail, with emphasis on the heterogeneity of the de-
veloping cell types.
Our study shows several anomalies in myeloid DC differentia-
tion and maturation in NOD and NOR (as compared with C57BL
and BALB/c) cultures that lead to a strongly decreased generation
of prototypic and mature DC. Furthermore, phenotypically mature
DC, when separated, appear to have various macrophage charac-
teristics and a reduced T cell-stimulatory capacity, despite normal
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expression levels of MHC and costimulatory molecules. The ab-
errant maturation of myeloid DC also occurs in Flt3 ligand (Flt3-
L)-stimulated BM cultures, which points toward an intrinsic defect
in myeloid DC development in mice with the NOD background.
Materials and Methods
Mice
Female NOD/Ltj (prediabetic), C57BL/6J, BALB/c, NOR/Lt, and C3Heb/
Fej mice 5–10 wk of age were used in this study. NOD/Ltj and C3Heb/Fej
mice were bred at the animal facility of the Erasmus MC (Rotterdam, The
Netherlands). C57BL, BALB/c, and female NOR mice were obtained from
Harlan (Horst, The Netherlands). Female C3HeB/FeJ mice were used as a
source of allogeneic responder T cells. Animals were specific pathogen free
and had free access to food and water in the animal care facility at the
Erasmus MC Rotterdam under the institutional guidelines for usage of
experimental animals.
mAbs and conjugates
mAbs were used for cell sorting, flow cytometric analysis and evaluation
of T cell activation in the MLR. Undiluted culture supernatants of the
hybridomas 2.4G2 (anti-FcRII/III-CD16/32), ER-MP21 (anti-transferrin
R-CD71), as well as unlabeled Ab against the scavenger R type I (SR-AI/
II-2F8; kindly provided by Dr. S. Gordon) were detected by FITC- or
R-PE-labeled goat anti-rat IgG (mouse-absorbed; GRa-FITC or GRa-
PE) purchased from Caltag Laboratories (San Francisco, CA). Directly
labeled 53-6.7FITC (anti-CD8), RM4-5PE (anti-CD4), and HL3PE (anti-
CD11c) were purchased from BD Biosciences (San Diego, CA). Biotin-
ylated ER-TR3 (anti-MHC class II; I-A) was kindly provided by BMA
Biomedicals (Augst, Switzerland) and 10-2.16 (anti-MHC class II for
NOD; I-Ag7) was produced, purified, and biotinylated in our laboratory.
These Abs were detected by R-PE (Caltag) or allophycocyanin (BD Bio-
sciences)-conjugated streptavidin.
rGM-CSF- and Flt3-L-stimulated BM cultures
Single-cell suspensions of BM, isolated from femora and tibiae, were pre-
pared as described previously (19). Total BM cells were cultured in RPMI
1640 (without HEPES; BioWhittaker, Walkersville, MD) supplemented
with 10% FCS (heat-inactivated; 0.2-m pore size filtered), 60 g/ml pen-
icillin, and 100 g/ml streptomycin (further referred to as culture medium).
Growth factors were used according to published protocols for DC gener-
ation (20, 21). In GM-CSF-stimulated cultures, a final concentration of 20
ng/ml recombinant GM-CSF (Biosource International, Camarillo, CA) was
used, whereas 100 ng/ml recombinant mouse Flt3-L (R&D Systems Eu-
rope, Abingdon, U.K.) was used in Flt3-L-stimulated cultures. Cells were
cultured at 37°C, 7% CO2 for various periods of time, as indicated, up to
10 days.
Cell suspensions
Cultured BM-derived cells were isolated from culture dishes by vigorous
pipeting to collect all cells. Cells were washed and kept until further use in
culture medium containing no additional growth factors. When used for
phenotypic analysis, cultured cells were washed with PBS supplemented
with 0.5% (v/v) BSA (Organon Teknika, Boxtel, The Netherlands) and 20
mM sodium azide. Single-cell suspensions of spleen and lymph nodes were
prepared and used for T cell isolation as described (11).
Cell sorting and flow cytometric analysis
For cell sorting, BM-derived cultured cells were labeled with two (anti-
CD11c and anti-MHC class II) mAbs as described previously (22). Before
sorting (FACSVantage; BD Biosciences), cell suspensions were filtered
over a 30-m pore size sieve (Polymon PES; Kabel, Amsterdam, The
Netherlands) to avoid clogging of the nozzle. After sorting, the purity of
the cell suspensions was checked by rerunning sorted samples, and purity
exceeded 95%. Suspensions were kept at 4°C throughout the staining and
sorting procedure. Sorted cells were counted in a Bu¨rker hemocytometer.
For phenotypic analysis by flow cytometry, samples of cultured cells
(2  105 cells) were aliquoted into 96-microwell plates (round-bottom;
Nunc, Roskilde, Denmark) and labeled with Abs as described before (22).
For dead cell exclusion, labeling with 7-aminoactinomycin D (7-AAD;
Molecular Probes Europe, Leiden, The Netherlands) was used before the
measurement (23). Events (3–5  104) were scored using a FACSCalibur
flow cytometer and analyzed by CellQuest software (BD Biosciences).
Analysis of the cell cycle and apoptosis
Apoptosis and cell cycle characteristics were determined by using a pro-
pidium iodide (PI) staining as previously described (24, 25). In short, 1 
106 cells were fixed in ice-cold ethanol for 2 h. Subsequently, cells were
incubated at room temperature for 30 min in PBS containing 0.02 mg/ml
PI, 0.1% v/v Triton X-100, and 0.2 mg/ml RNase; left overnight at 4°C;
and analyzed with FACSCalibur. Doublet cells were excluded from the
analysis by measuring peak area and width. The number of proliferating
cells was determined by gating the region of the DNA histogram that
contained cells in G1-G0, S, and G2-M phases of the cell cycle. The per-
centage of apoptotic cells was determined by gating the sub-G1 peak in the
same DNA histogram.
Cytochemistry
The acid phosphatase (AP) activity of the various culture-derived popula-
tions was determined using cytospins of sorted cells prepared on a cytospin
apparatus (Nordic Immunological Laboratories, Tilberg, The Netherlands).
Cytospins were air dried and used for the AP staining according to the
method of Katayama et al. (26), using naphthol AS-BI phosphate as a
substrate and a hexazotized pararosanilin as a coupling agent (37°C, 30
min). Slides were counterstained with hematoxylin. Preparations were
mounted in DePex mounting medium (Gurr, BDH, Poole, U.K.).
Stained cytospins were quantified by counting a minimum of 300 cells/
sample. For each mouse strain, four independent samples per experiment
were counted using the following characterization. AP stains the lysosomal
compartment (27), and on the basis of the staining intensity and distribution
we classified four different staining patterns: negative cells (granulocytes
and myeloid precursors); weak cytoplasmic staining (cells with several
small positive lysosomes, immature DC (28)); strong cytoplasmic staining
(cells with strong AP activity in numerous lysosomes spread throughout
the cytoplasm, typical for macrophages (29); and single-dot staining (ma-
ture DC with a dot-like AP-active region located in the cell center (28).
MLR assay
The capacity of in vitro generated BM-derived cells to activate allogeneic
T cells was measured as previously described (19). Briefly, stimulator cells
(cultured DC) and responder T cells, isolated from lymph nodes, were
resuspended in RPMI 1640 supplemented with 25 mM HEPES, 10% FCS
(heat inactivated; 0.2-m pore filtered), 60 g/ml penicillin, 100 g/ml
streptomycin, 20 mg/L sodium pyruvate, and 50 M 2-ME (further re-
ferred to as MLR medium). T cells were resuspended at a concentration of
106/ml, and the concentration of stimulator cells varied depending on the
desired stimulator-responder cell ratio. The cells (100 l of each cell sus-
pension) were incubated in round-bottom 96-well plates for 4 days at 37°C
in 7% CO2. Stimulator and responder cells, incubated separately in MLR
medium, were used as negative controls. Mitogenic stimulation of T cells
by Con A (final concentration, 1.25 g/ml) (Sigma-Aldrich, St. Louis,
MO) was used as a positive control.
We used induced expression of the transferrin receptor (TfR/CD71) as
a measure for T cell proliferation in the MLR, because the iron uptake
through transferrin by stimulated cells has been shown to be a necessary
requirement for their proliferation (30). Control experiments demonstrated
that results obtained by [3H]thymidine incorporation correlated directly
with the results obtained with our method using the CD71/TfR expression
detection (Ref. 19) and our unpublished data). In addition, we compared
the kinetics of the CD71/TfR expression with other activation markers
(CD25, CD69) on allogeneic T cells stimulated by in vitro generated NOD
DC. The expression pattern of CD71/TfR was similar to the expression of
CD25 or CD69; therefore, we chose to use CD71/TfR expression analysis
as a representative readout of the T cell stimulation in the allogeneic MLR.
After 4 days of coculture, cells were harvested and analyzed by flow
cytometry. Triple labeling of cells with anti-CD4, anti-CD8, and anti-
CD71/TfR Abs was performed, and 1.5 104 events were acquired within
the live-cell gate. Data was analyzed using CellQuest analysis software.
The percentage of CD71/TfR-positive cells was determined within the
CD4 and CD8 population.
Statistical analysis
Statistical analyses were done by a paired two-tailed Student t test using the
SPSS software package to determine differences within the means of the
sample groups. Results are presented as the mean SEM, unless otherwise
indicated.
4343The Journal of Immunology
Results
Low yield of DC in GM-CSF-stimulated NOD BM cultures is
caused by reduced proliferation and increased apoptosis
The capacity of NOD BM precursors to generate DC in vitro has
been studied previously, and several groups reported a low yield of
cells in NOD cultures stimulated with GM-CSF alone (12–14, 17).
Similarly, we found that NOD cultures on average contained a
significantly lower number of cells than the cultures from C57BL
and BALB/c mice ( p  0.01). (Fig. 1A). This appeared not to be
caused by a decreased frequency of GM-CSF-responsive precur-
sors in NOD BM as determined by limiting dilution analysis (data
not shown). Interestingly, the yield of cells in NOR cultures was
similar to those in C57BL and BALB/c mice (Fig. 1A).
To study the events causing the low yield of cells in NOD cul-
tures stimulated with GM-CSF, we followed kinetic changes in the
number of proliferating vs apoptotic cells at different time points of
the culture (days 2, 5, and 7) by labeling the nuclear DNA content
with PI. Proliferation appeared to be quite constant during the cul-
ture, but the different mouse strains had different proliferation rates
(Table I). Of three mouse strains tested, BM cells from the C57BL
mouse showed the highest proliferation rate, significantly higher
than the NOD mouse at days 5 and 7 ( p 0.01). The proliferation
rate in the BALB/c culture was on average also higher than in the
NOD culture, but this difference did not reach statistical signifi-
cance, except for day 5 of the culture ( p  0.05). Therefore, in-
creased proliferation partly contributed to the higher cell number
in the culture of the control strains.
Using the same DNA staining, we could determine apoptosis in
the cultures (cells with the nuclear content 2n) and found the
highest percentage of dead cells at the earliest time point (day 2)
in all cultures (Table I). This was due to apoptosis of many BM
cells unable to respond and survive when stimulated by GM-CSF
(mature granulocytes or cells that belong to the erythroid and lym-
phoid lineage). At later time points, the number of apoptotic cells
decreased in the C57BL and BALB/c cultures, which was not the
case in NOD cultures. Therefore, the observed higher cell death in
NOD cultures additionally contributed to the lower yield at the end
of the culture period. NOR mice were not tested in this assay.
A more sensitive method to quantify dead cells at the end of the
culture was the uptake of 7-AAD shortly before the sample acqui-
sition. Using this method, we found an even more pronounced
difference in the frequency of dead or dying cells in NOD cultures.
Significantly higher percentages were found in NOD cultures than
in C57BL and BALB/c cultures ( p  0.01; Fig. 1B). NOR mice
were also tested, and the percentage of dead cells was higher in
NOR than in C57BL and BALB/c cultures. Therefore, NOR mice
show aberrance regarding cell apoptosis similar to NOD, yet cell
yield is normal and comparable with those of C57BL and BALB/c
mice (Fig. 1).
Diverged differentiation of BM cells to macrophages in NOD
and NOR cultures
To investigate the possibility that NOD BM precursors demon-
strated reduced proliferation and augmented apoptosis due to an
aberrantly fast maturation, we analyzed BM cultures at different
time points by double labeling for CD11c and MHC class II. From
the expression pattern of these two markers, three DC develop-
mental stages can be defined in normal BM cultures (Ref. 20 and
morphological analysis below): granulocytes and myeloid precursors
(CD11cMHCII), immature DC (CD11cMHCIImedium), and ma-
ture DC (CD11cMHCIIhigh). These three subsets were phenotyp-
ically easily discerned in cultures of C57BL mice (Fig. 2) as well
as other control mouse strains (data not shown). In addition, a
small population of CD11cMHCII cells was found in all BM
cultures. These cells are considered to be monocytes/macrophages
(M. Lutz, unpublished observations; see also below) and they mea-
sured 10% of viable cells in cultures of control mice.
In comparison to C57BL, the developing NOD BM cultures
showed a strikingly different cellular composition over time. At
days 2 and 5 of culture, reduced frequency of CD11c cells was
found in NOD cultures (6% in NOD vs 13% in C57BL and 24%
in NOD vs 46% in C57BL, for days 2 and 5, respectively; Fig. 2).
This difference was less pronounced at day 7 of culture (55% vs
64% CD11c cells in NOD and C57BL, respectively). However,
in marked contrast to the C57BL cultures, at day 7 the majority of
CD11c cells in NOD culture were MHC class II, and a signif-
icantly reduced proportion of cells expressed MHC class II mol-
ecules (17% in NOD cultures as compared with 58%
CD11cMHCII cells in C57BL). From these data, we concluded
that in response to GM-CSF, NOD BM precursors do not show fast
Table I. Proliferation and apoptosis analysis of BM cultures at different time points
Day of Culture
Proliferationa Apoptosisb
NOD C57BL BALB/c NOD C57BL BALB/c
2 18.1  3.8 26.5 3.7 19.9  4.5 25.8 7 20.1  4.9 23.1 9.7
5 11.4  0.5 23.2 1.7c 19.0  1.4d 11.4  3.2 4.7 1.6 10.5 2.1
7 15.0  1 24.6  2.1c 19.7  1.9 9.4 2.2 3.1 0.3 6.0 1.9
a Average frequency (SEM) of cells with nuclear content 2n.
b Average frequency (SEM) of cells with nuclear content 2n.
c p  0.01 NOD vs C57BL.
d p  0.05 NOD vs BALB/c.
FIGURE 1. Low cell yield and increased cell death in NOD GM-CSF-
stimulated BM cultures. Total BM was stimulated with GM-CSF for 7 days
in vitro. A, Total yield of viable cells from NOD cultures was significantly
lower than from NOR, C57BL, or BALB/c cultures. Data represent average
values  SEM derived from 2 (of 10 performed) experiments in which the
BM from all 4 strains was cultured simultaneously. p  0.01 NOD vs
C57BL and p 0.05 NOD vs NOR and BALB/c. B, The frequency of dead
(7-AAD) cells at day 7 of culture in NOD is significantly higher than in
C57BL and BALB/c but not higher than in NOR cultures. Values are the
average  SEM derived from all 10 experiments. p  0.01 NOD vs
C57BL and BALB/c.
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maturation to myeloid DC but, in contrast, a deviated maturation
into CD11cMHCII cells.
Cells from BM cultures of NOR mice displayed a CD11cMHCII
staining pattern similar to that of NOD cultures. At day 7 of culture,
NOR cultures contained 27% myeloid precursors (CD11cMHCII),
22% monocytes/macrophages (CD11cMHCII), 29% immature
DC (CD11cMHCIImedium), and 21% DC with mature phenotype
(CD11cMHCIIhigh).
Further, we analyzed the expression of the costimulatory mol-
ecules CD40, CD80, and CD86 by the different subsets, distin-
guished on the basis of MHC class II expression (Fig. 3). Expres-
sion of costimulatory molecules by cells derived from mice of the
NOD background (NOD and NOR) was similar to those of the
control cultures. Mature DC (CD11cMHCIIhigh) from NOD and
NOR cultures, although present at a reduced frequency, expressed
similar levels of CD40, CD80, and CD86 compared with the
C57BL and BALB/c. Immature, MHC class IImedium DC in all
mouse strains were CD80low, CD86low, and CD40, whereas MH-
CII cells were negative for all three markers showing again that
these cells in NOD and NOR cultures were not DC that merely
failed to up-regulate MHC class II molecules.
Taken together, subset analysis of BM cultures showed that
NOD and NOR precursors have a decreased potential to develop
into DC (MHCIICD11c) when stimulated by GM-CSF. How-
ever, the relatively few immature (MHCIIlowCD11c) and mature
(MHCIIhighCD11c) DC that develop in these cultures express
normal levels of costimulatory molecules on their cell surface.
Poor stimulatory capacity of DC generated in GM-CSF cultures
from NOD and NOR mice
In addition to the different frequency of mature DC, BM cultures
showed different strain-specific capacities to stimulate T cells in
the allogeneic MLR (Fig. 4). In two independent experiments,
NOD as well as NOR DC failed to stimulate significant expression
of CD71/TfR on the surface of allogeneic (C3H) T cells upon 4
days of coculture (Fig. 4, A and B). In control experiments, we
excluded the low response of T cells due to the responder mouse
strain as a possible cause for the low MLR outcome. In addition,
poorer MLR capacity of stimulators from NOD and NOR cultures
did not originate from the MHC diversity with the controls, be-
cause DC of the congenic NODH2b mice with the MHC region
derived from C57BL strain showed the same NOD-like low stim-
ulation capacity (data not shown). Taken together, GM-CSF-gen-
erated DC from the mice that share the NOD background also
share a poor stimulation capacity.
The poor stimulation capacity of NOD and NOR DC could not
be overcome by an additional maturation stimulus. Unlike DC
from C57BL and BALB/c cultures, NOD and NOR DC failed to
increase their T cell activation potential when stimulated overnight
with 100 ng/ml LPS (Fig. 4C). However, the quality of T cells
stimulated by any of the strains was similar with respect to the
cytokine production; they produced significant amounts of IFN-
and little IL-4 or IL-10 and therefore were Th1-like. When calcu-
lated per cell, all T cells produced similar levels of cytokines ir-
respective of the origin of DC by which they were stimulated (data
not shown).
The very low frequency of mature DC in NOD cultures ob-
served in phenotypic analysis might have been the reason for the
poor performance of the whole population in the MLR. Therefore,
BM subsets were purified by cell sorting and cocultured with al-
logeneic T cells (Fig. 5). Although devoid of potential inhibitory
cells and present in the same numbers as in the control, purified
FIGURE 2. Deviated development of NOD DC in vitro. GM-CSF-stim-
ulated cells from NOD and control (C57BL) were harvested at different
time points and labeled with CD11c and MHC class II Abs. After gating
out dead cells (7-AAD), at days 2 and 5 of culture, a reduced percentage
of CD11c cells was present in NOD culture. Up-regulation of MHC class
II in NOD cultures was also diminished, leading to the development of
fewer mature DC (CD11cMHCIIhigh) in culture. In addition, an increased
percentage of CD11cMHCII cells developed. Numbers indicate the per-
centage of cells in the quadrants. Dot plots are representative of five sep-
arate experiments with similar results.
FIGURE 3. Few mature DC (CD11cMHCIIhigh) develop in NOD and
NOR cultures, but they show normal expression of costimulatory mole-
cules. NOD, NOR, C57BL, and BALB/c cells obtained from 7-day GM-
CSF-stimulated BM cultures were double-labeled with MHCII and CD80,
CD86, or CD40 mAbs. Dot plots show all culture-derived cells, after gating
out dead cells (7-AAD). Representative dot plots are shown for each
mouse strain from the same experiment. In total three to seven independent
cultures per mouse strain have been performed with similar results.
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mature NOD DC (CD11cMHCIIhigh) failed to stimulate T cells
to a significant level when compared with C57BL mature DC (Fig.
5E). The percentage of T cells that had up-regulated CD71/TfR
when stimulated by NOD mature DC (Fig. 5E) was rather com-
parable with the proportion induced by the immature DC or mono-
cytes/macrophages from C57BL culture (Fig. 5, C or D). Other pu-
rified subpopulations from NOD cultures also exhibited lower
stimulatory capacity than the corresponding C57BL subpopulations.
Morphology of mature DC in NOD cultures is similar to the
immature DC from the C57BL
To characterize further the four cell subsets identified in flow cy-
tometric analysis (see before), we investigated the morphology of
cells separated by cell sorting from day 7 BM culture on the basis
of their differential expression of CD11c and MHC class II mol-
ecules (Fig. 6A). As shown in Fig. 6B, the CD11cMHCII (R1)
population contained myeloid precursors (slightly indented large
nucleus with more basophilic cytoplasm) and neutrophilic granu-
locytes (typical segmented nucleus) in both NOD and C57BL cul-
tures. The CD11cMHCII (R2) fractions, abundantly present
only in NOD, contained morphologically distinguishable mono-
cyte/macrophage-like cells in both cultures (asymmetrically posi-
tioned oval or kidney-shaped nucleus and a high cytoplasm-nu-
cleus ratio). The CD11c/MHCIImedium (R3) cells derived from
C57BL BM resembled immature DC (relatively large cells with an
oval nucleus on one cell side and a large cytoplasm, more regular
in shape) which formed relatively large clusters. In contrast, cells
of the same CD11cMHCIImedium population in NOD cultures
hardly formed any clusters. Finally, CD11cMHCIIhigh (R4) cells
from C57BL cultures had an irregular shape and a number of den-
dritic protrusions, thus resembling mature DC that mostly occurred
as single cells or formed small clusters. The morphology of phe-
notypically mature DC separated from NOD cultures did not differ
significantly from their C57BL counterparts, but they formed large
clusters comparable with those of immature C57BL DC.
Mature NOD and NOR myeloid DC express higher levels of
markers typical for macrophages
The defective T cell stimulatory capacity and large cluster forma-
tion of separated mature DC from NOD BM cultures prompted us
to investigate their phenotype further. Because NOD BM precur-
sors seem to develop more readily into monocytes/macrophages
(CD11cMHCII) in vitro, we focused on macrophage markers in
particular. As shown in Fig. 7, mature DC (CD11cMHCIIhigh
cells) from C57BL cultures express very low to negative levels of
FcR II/III, scavenger R, F4/80, and Gr-1. In contrast, much
higher levels of these markers were found on mature NOD DC.
When quantified from other mouse strains (Table II), tested
markers were higher on mature DC from NOD mice than on
both C57BL and BALB/c mature DC. Interestingly, scavenger
R and F4/80 were expressed on the NOR mature DC in a
FIGURE 5. Poor capacity of sorted mature DC from NOD BM cultures
to stimulate T cells. Sorted cells from 7-day cultures were cocultured with
allogeneic T cells at different APC-T cell ratios. Data are presented as
percentage of T cells that express CD71/TfR. Unseparated NOD culture-
derived cells were virtually unable to stimulate T cell proliferation, in
contrast to their C57BL counterparts. As expected, purified mature DC
(CD11cMHCIIhigh) from the C57BL culture displayed the highest stim-
ulating capacity, whereas NOD mature DC were poor stimulators even
when purified. Data are representative of two experiments performed in-
dependently, with similar results. Mac, Macrophages; mono, monocytes;
LN, lymph nodes.
FIGURE 4. Poor stimulatory capacity of total culture-derived cells generated from NOD and NOR mice. A and B, Total BM culture-derived cells were
cocultured for 4 days with allogeneic T cells from C3HeB/Fej mice in different APC-T cell ratios. The capacity of total culture cells from NOD mice is
compared with those of C57BL or BALB/c mice in experiment 1 and with NOR or BALB/c mice in experiment 2. In contrast to the other two mouse strains,
NOD and NOR cells exhibited similar poor stimulatory capacity. C, LPS stimulation increased the stimulation potential of BM cells from all four strains.
However, stimulated NOD and NOR cells exhibited again a much lower stimulatory capacity than C57BL or BALB/c cells. Data present the percentage
of T cells (CD4 and CD8) that express CD71/TfR as indication of their productive stimulation by APC. A representative of at least three independent
MLR cultures for each mouse strain is shown.
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manner similar to that of the NOD, whereas FcR II/III and
Gr-1 values were intermediate between the NOD and the other
two strains.
Mature DC from NOD cultures contain an abnormally high
percentage of macrophage-like cells with a strong lysosomal
activity
To assess the putative macrophage-like nature of mature DC gen-
erated in NOD cultures, we performed cytochemical staining of
AP (for categorization/scoring, see Materials and Methods) in
sorted cell populations (Fig. 8A). Initial examination revealed that
the AP pattern of the sorted populations from the C57BL cultures
overlapped to a great extent to their phenotype. This was not the
case in sorted cells from NOD cultures. When quantified (Fig. 8B),
the R3 population from NOD cultures with the phenotype of im-
mature DC also included a significant percentage of cells with a
lysosomal activity typical of macrophages (strong cytoplasmic
staining) (49% for NOD vs 8.3% for C57BL). An even more pro-
nounced difference between NOD and C57BL existed in the sorted
CD11cMHCIIhigh population (R4) of phenotypically mature DC.
This population isolated from NOD cultures contained few cells
with the staining pattern typical of mature DC (single-dot staining;
3.3% for NOD vs 83% for C57BL) and a remarkably high per-
centage of cells with staining like that of macrophages (67.3% for
NOD vs 7.7% for C57BL).
To investigate whether this low percentage of real mature DC
and a high percentage of macrophages in the alleged mature DC
population is indeed NOD specific, we sorted mature
CD11cCD86 DC from 7-day GM-CSF-stimulated cultures
from NOD, NOR, C57BL, and BALB/c cultures and quantified
the AP staining. As shown in Fig. 8C, NOD cells contained
FIGURE 7. Elevated expression of monocyte/macrophage markers by
mature NOD DC (CD11cMHCIIhigh) generated with GM-CSF. Cells
were triple-labeled with CD11c, MHCII and a marker of interest. The light
gray line indicates a histogram of the isotype control; the histogram indi-
cated with the black line represents the marker expression by mature DC
from NOD and the dark gray line of C57BL cells. Histograms are derived
from a representative staining of at least six independent experiments per
mouse strain.
FIGURE 6. Morphological analysis of cells in GM-CSF-stimulated culture shows similar subpopulations in NOD and control cultures. A. Four sub-
populations of cultured cells can be defined with MHCII and CD11c: (R1) CD11c/MHCII; (R2) CD11c/MHCII; (R3) CD11c/MHCIImed and (R4)
CD11c/MHCIIhigh. Represented gates are used for cell sorting. B. Sorted cells are morphologically identified as follows: R1-myeloid precursors and
neutrophils; R2- monocytes (mono)/macrophages (Mac); R3, immature DC; R4, mature DC (more details in Results). Magnification, 126.
4347The Journal of Immunology
significantly fewer cells with single-dot staining of mature DC
than NOR, C57BL or BALB/c cells. However, both NOD and
NOR contained more immature DC (weak cytoplasmic stain-
ing). Importantly, specifically CD11cCD86 DC from NOD
cultures contained significantly more cells with strong cyto-
plasmic (macrophage-like) AP staining than any other strain
tested.
Aberrant myeloid DC development from NOD BM precursors
stimulated with Flt3-L
It might be argued that the aberrant response we observed mirrors
the defect of NOD BM cells to respond to GM-CSF, rather than an
inherent difficulty to develop into normal DC in culture. Flt3-L
stimulates the development of both myeloid and plasmacytoid DC
from mouse BM. Therefore, we cultured NOD, C57BL, and
BALB/c BM with Flt3-L according to the method of Gilliet et
al. (21)
Similar to our findings for GM-CSF-stimulated cultures, the
yield at day 10 of the Flt3-L-stimulated cultures was lower from
NOD precursors than from controls. In two independent exper-
iments, the total cell yield in NOD cultures was 56 and 43% of
Table II. Intensity of monocyte/macrophage marker expression on










FcRII/III 118 53b 59  6 38  22 44
Scavenger R 162  27 192  6 11  3 33
F4/80 148  20 133  8 28  4 31
Gr-1 108  26 70  5 11  4 7
a Number of samples derived from a representative staining
b Average mean fluorescence intensity. ( SEM).
FIGURE 8. NOD mature DC have strongly increased acid phosphatase activity. A, Cytocentrifuge preparations of sorted cells were stained for AP and
then counterstained with hematoxylin. PMN, Polymorphonuclear cells; mono, monocytes; Mac, macrophages. Magnification,285. B, Distribution of cells
with different staining-pattern (see Materials and Methods) in three indicated sorted populations from the NOD and C57BL cultures. Populations with a
phenotype of immature and mature DC from NOD cultures contained a high number of cells with a strong AP activity (red area of the bar). Mf,
macrophages; iDC, immature DC; mDC, mature DC. C, Composition of the separated mature DC population (CD11cCD86) from four different mouse
strains (NOD, NOR, C57BL, and BALB/c) with respect to the three cell types defined by the AP pattern (strong cytoplasmic staining, macrophages; weak
cytoplasmic staining, immature DC; single-dot pattern, mature DC). NOD and NOR cells contained more immature DC and fewer mature DC as judged
by their AP activity. High frequencies of cells with a high macrophage-like AP activity were found only in the NOD CD11cCD86 population. Data for
A and B are representative of two independent experiments; C shows an average value  SEM of four independent sortings for each mouse strain.
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the C57BL and 67% of the BALB/c cultures. When analyzed by
flow cytometry, the proportion and the phenotype of plasmacy-
toid CD11cCD11b cells did not differ significantly among
the strains (Fig. 9). In contrast, the NOD cultures contained
particularly fewer myeloid CD11cCD11b DC (16.2% in
NOD vs 32.3 and 28.1% in C57BL and BALB/c, respectively)
(Fig. 9A). Additionally, the phenotype of myeloid DC in NOD
Flt3-L-stimulated cultures exhibited phenotypic abnormalities
(Fig. 9B) similar to those in GM-CSF-stimulated cultures. NOD
myeloid DC failed to reach a mature phenotype, unlike the
control, in that they were primarily MHC class IIlow, CD80,
and Gr-1.
Therefore, the deviated development of myeloid DC in both
Flt3-L and GM-CSF-stimulated cultures suggests an inherent ab-
normality in myeloid differentiation, rather than an aberrant re-
sponse to a specific cytokine.
Discussion
The results presented in our study demonstrate several anomalies
in the generation of myeloid DC from BM precursors in vitro in
NOD and NOR mice: 1) a low cell yield from BM precursors was
specific for the NOD and not found in NOR mice; 2) both NOD
and NOR showed an increased cell death of BM DC precursors,
but this was more outspoken in the NOD mouse; 3) an abnormally
increased frequency of macrophages was found in GM-CSF-stim-
ulated NOD and NOR BM cultures.
In addition, CD11cMHCIIhigh DC with an aberrant phenotype
and macrophage-like AP activity were generated in NOD cultures.
We conclude that myeloid precursors from NOD mice stimulated
with GM-CSF predominantly mature into macrophage-like cells.
Similar phenotypic abnormalities were evident in NOD myeloid
DC generated with Flt3-L, indicating an intrinsic deficiency of the
precursors of mice with an NOD background in developing into
real myeloid DC. The fact that only part of the NOD-associated
anomalies in the generation of DC were present in the NOR un-
derscores the multigenic complexity of the DC differentiation
problems in mice of the NOD background.
Our first finding of the significantly lower yield of DC from
NOD BM precursors in vitro is in agreement with previous reports
(13, 14, 17). Furthermore, we demonstrated that in NOD/Ltj mice
a combined low proliferation and an increased apoptosis of GM-
CSF-stimulated BM precursors lead to such observed low cell
yield. Our data concur with recently reported findings of a lower
proliferation and an increased apoptosis of DC precursors in the
congenic NOD H-2k mouse (31). Together, these data idncate an
intrinsic problem of proliferation and apoptosis of DC precursors
under the control of NOD-specific genes independent of the H-2g7
MHC region. NOR mice that share several gene segments with the
NOD mouse (including the H-2g7 MHC region) (32) also shared
part of the high apoptosis in the BM culture with NOD but had no
problems in generating a normal cell yield.
Follow-up of DC maturation in NOD and NOR cultures re-
vealed additional anomalies: BM-derived cells ineffectively differ-
entiated into CD11cMHCIIhigh prototypic DC and a significant
proportion of CD11c cells did not express MHC class II and
costimulatory molecules. The latter cells were not immature DC
incapable to bring MHC class II molecules to the cell surface, as
evaluated by immunocytochemistry. Additionally, 24-h stimula-
tion with LPS failed to induce maturation of these cells into typical
mature DC. This, together with the morphology and phenotype of
FIGURE 9. Aberrant generation of NOD myeloid DC in Flt3-L-stimulated cultures. BM cells were stimulated as reported by Gilliet et al. (21). A,
Representative dot plots of CD11c/CD11b staining indicate the development of different DC subsets under the influence of Flt3-L. Numbers express the
frequency of plasmacytoid (CD11cCD11b) and myeloid (CD11cCD11b) DC in NOD and control (C57BL and BALB/c) cultures. B, Histograms show
the phenotype of plasmacytoid and myeloid DC in NOD vs control. Vertical line, Upper threshold of the negative control; black line, marker expression
of gated plasmacytoid or myeloid DC in NOD culture; gray line, marker expression of the corresponding population in control culture. NOD myeloid DC
displayed a similar deviant phenotype as observed in GM-CSF-stimulated culture. Plasmacytoid DC obtained from NOD and C57BL BM precursors had
comparable phenotypes. Similar data were obtained in two independent experiments.
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the cells, supports the notion that the numerous CD11cMHCII
cells in NOD and NOR cultures were monocytes and macrophages
and not DC. The codevelopment of macrophages during in vitro
culture of BM precursors with GM-CSF has been reported previ-
ously in normal non-autoimmunity-prone mice (33). Likewise, we
found CD11cMHCII monocytes/macrophages in control cul-
tures, but the frequency of these cells was very low in controls and
noteworthy in NOD and NOR. Therefore, our data suggest that the
decreased frequency of mature DC results from a deviated differen-
tiation of myeloid precursors into macrophages (rather than DC) in
BM cultures of mice with the NOD background.
A further abnormality we detected was that CD11cMHCIIhigh
CD86 DC from NOD cultures that did express costimulatory
molecules and approached the phenotype of prototypic mature DC
the best nevertheless had low T cell stimulation capacity, ex-
pressed increased levels of monocyte/macrophage markers, and
had an abnormally high percentage of cells with a strong AP ac-
tivity. These phenotypically mature DC therefore seemed more
related to macrophages (hence we called these cells macrophage-
like DC). Interestingly, DC from NOR mice shared properties with
the NOD DC like a similar low maturation rate, a poor T cell
stimulatory capacity, and some of the macrophage characteristics,
such as the higher expression of scavenger R and F4/80. However,
NOD cultures exclusively contained a high percentage of macro-
phage-like DC as judged by AP.
Our data once more indicate the complexity of the gene back-
ground determinants that establish various deviations in the devel-
opment of DC from BM precursors in mice with the NOD back-
ground. According to Prochazka et al. (32), NOR mice possess
C57BL/KsJ-derived genes on chromosomes 2, 4, 11, and 12. The
remaining markers on 14 chromosomes, including the diabeto-
genic H-2g7 complex on chromosome 17, are of NOD origin. In-
terestingly, NOR mice, although diabetes resistant, share with
NOD mice the T lymphocyte accumulation in peripheral organs
and a depressed IL-1 secretion by peritoneal macrophages; unlike
NOD, however, NOR mice have a robust suppressor T lymphocyte
function.
The mechanisms that lead to the aberrant generation of DC in
NOD cultures remain elusive. They might originate from intrinsic
and genetically determined defects in BM precursors, or they
might be induced by the numerous macrophages present and aris-
ing in the NOD cultures. Studies have been published that provide
circumstantial support for each of the two possibilities (34–40).
With regard to the intrinsic defects in BM DC precursors, a
deficient up-regulation of the GM-CSF receptor or an abnormal
downstream signaling from the receptor are good candidates for
the abnormal cell maturation and increased cell death in culture,
particularly in view of the defective response of NOD myeloid
precursors to GM-CSF and IL-5, which share the signaling chain
of the receptor (34). However, we show that aberrant myeloid DC
also develop when Flt3-L is used as the stimulator, signaling
through a different receptor. Hence, we consider aberrations in a
common signaling pathway more likely. Several studies thus far
have shown abnormalities in NF-B degradation in NOD spleno-
cytes and in vitro-derived NOD APC (35, 36). It would be inter-
esting to investigate whether similar defects can also be found in
NOD and NOR DC precursors, thus at an earlier developmental
stage.
Alternatively, the numerous macrophages present in the culture
might inhibit a normal maturation of DC in the NOD and NOR
cultures. Presence of macrophages in a culture is usually consid-
ered to be beneficial because they produce TNF- and thereby
support spontaneous maturation of DC (37). However, the abnor-
mal cytokine profile that has been shown for NOD macrophages
(38) might make them inhibitory instead of supportive for the
growth and maturation of DC in culture. A potential inhibitory
cytokine might be IL-6 as it has been shown that IL-6 shifts the
differentiation of human monocytes from DC toward macro-
phages, whereas TNF- favors maturation into DC (39, 40); how-
ever, in the supernatants collected from day 7 BM cultures, we
could not detect appreciable levels of TNF-, IL-6, or IL-1, and
when stimulated with LPS, C57BL and NOD BM-derived cells
produced similar levels of these cytokines (data not shown). There-
fore, it is less likely that an increased production of inhibitory
cytokines in NOD cultures is the decisive factor in the deviated DC
generation. However, macrophages in the GM-CSF-stimulated
NOD and NOR cultures could still inhibit DC maturation by direct
cell-cell interactions or by soluble factors produced at earlier
stages in the culture.
An important difference between our current investigation and
previous studies, in which an increased generation or enhanced
stimulatory capacity of DC generated from NOD BM have been
reported (15, 16), is that we did not use IL-4 in our culture system.
A supportive effect of IL-4, added to GM-CSF, for the generation
and maturation of NOD BM-derived DC was observed in several
studies before (13, 14, 41, 42). Also, in our hands, NOD cultures
showed an improved DC yield and stimulatory capacity in MLR
when cultured with IL-4 added to GM-CSF (our unpublished ob-
servation). Normally, IL-4 is not added to GM-CSF-driven DC
culture in mice because GM-CSF alone is considered sufficient for
the optimal generation of DC from the mouse BM (20). However,
unlike other mouse strains, BM precursors from NOD mice ap-
parently critically depend on the presence of IL-4 for a normal and
optimal development of DC. IL-4 inhibits macrophage outgrowth
in the culture (43), but it may also function by increasing the sen-
sitivity of the cells for DC maturation factors such as TNF- (44).
Whatever the mechanism may be, the beneficial effect of IL-4 in
NOD cultures suggests a subtle intrinsic deficiency in NOD BM
precursors for development into mature DC. This deficiency, mag-
nified in vitro, might not be a decisive factor leading to obviously
malfunctioning DC in vivo but probably contributes to the sensi-
tivity of the DC system in NOD and NOR mice, which may be
more prone to imbalance when challenged by external triggers in
the NOD and protected by C57BL-inherited genes in the NOR
mouse. In such a way, this subtle abnormality in DC differentiation
might contribute to the autoimmune-prone genetics of NOD mice.
However, because these anomalies are also largely present in NOR
mice, they are certainly not sufficient to precipitate autoimmune
diabetes on their own.
It is unclear whether the correlate of a macrophage-like DC that
we find in NOD BM culture exists in vivo. GM-CSF-stimulated
culture might be considered a system in which inflammation-re-
lated DC are generated; therefore, one could imagine that NOD
myeloid precursors could encounter similar problems to undergo
normal maturation during inflammation in vivo. The immature
CD11cMHCIIlow DC produced under such circumstances would
be the correlate of our macrophage-like DC in vitro. Findings from
a recent study support this idea because NOD cells increasingly
develop into CD11cMHCIIlow DC when reconstituting mixed
bone marrow chimeric mice (31). Further studies on development
and function of different DC subsets in the NOD mouse in steady state
and inflammation would be necessary to confirm or reject this
hypothesis.
In conclusion, in this study we describe an anomaly of
myeloid BM precursors in NOD and NOR mice to develop
preferentially into macrophages and abnormal macrophage-like
DC when stimulated in vitro. Potentially, this defect contributes
to the dysfunctional regulation of tolerance in NOD mice.
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